XML 40 R25.htm IDEA: XBRL DOCUMENT
v3.25.1

SIGNIFICANT AGREEMENTS AND CONTRACTS (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract] |
Schedule of Collaborative Agreement Liabilities and Revenues Disaggregated by Timing of Revenue Recognition | The following table presents collaboration revenue under the Janssen Collaboration Agreement for the three months ended March 31, 2024 (in thousands):
|  |  | Three Months Ended March 31, |  |
|  |  | 2024 |  |  |  |
Revenue from Janssen Collaboration Agreement: |  |  |  |  |  |  |
Over Time: |  |  |  |  |  |  |
Research and Development Services |  |  | $ | 971 |  |  |  |  |
Clinical Supply Services |  |  | 2 |  |  |  |  |
Total Revenue from Janssen Collaboration Agreement |  |  | $ | 973 |  |  |  |  |
The following table presents collaboration and product revenue, included within discontinued operations, disaggregated by collaborator and timing of revenue recognition, for the three months ended March 31, 2024 (in thousands):
| Three Months Ended March 31, 2024 |  |
| Mundipharma |  | Melinta |  |  |  |
Revenue from Collaboration, License and Commercial Agreements: |  |  |  |  |  |  |
Point in Time: |  |  |  |  |  |  |
License of Intellectual Property - upon milestone achieved | $ | 813 |  |  | $ | — |  |  |  |  |
Product Revenue | 2,826 |  |  | — |  |  |  |  |
Royalty Revenue | 26 |  |  | 76 |  |  |  |  |
Over Time: |  |  |  |  |  |  |
Research and Development Services | 3,266 |  |  | 317 |  |  |  |  |
Clinical Supply Services | 166 |  |  | — |  |  |  |  |
Total Revenue from Collaboration, License and Commercial Agreements | $ | 7,097 |  |  | $ | 393 |  |  |  |  |

X
- References No definition available. + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 808 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1 + Details
Name: | us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration